FDA
approval
· 2019-12-06
FDA Approved: TOBRAMYCIN INHALATION SOLUTION PAK — Supplemental Application (Genericus, Inc.)
Summary
FDA approved a supplemental application to authorize Genericus, Inc. to market a generic tobramycin inhalation solution PAK.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TOBRAMYCIN INHALATION SOLUTION PAK (TOBRAMYCIN)